CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors

By Ul-Haq Zaheer-   Wadood Abdul   Uddin Reaz  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 1, 2009-02 ,pp. : 272-278

Informa Healthcare

Access to resources Recommend Favorite

Predicting anti-cancer activity of quinoline derivatives: CoMFA and CoMSIA approach

By Vaidya Ankur   Jain Abhishek Kumar   Kumar Prashantha   Kashaw Sushil Kumar   Agrawal Ram Kishore  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 26, Iss. 6, 2011-12 ,pp. : 854-861

Informa Healthcare

Access to resources Recommend Favorite

Docking, CoMFA and CoMSIA studies of a series of sulfonamides derivatives as carbonic anhydrase I inhibitors

By Ghasemi Jahan B.   Meftahi Nastaran  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 28, Iss. 2, 2013-04 ,pp. : 320-327

Informa Healthcare

Access to resources Recommend Favorite

Three-dimensional quantitative structure-activity relationship (CoMFA and CoMSIA) studies on galardin derivatives as gelatinase A (matrix metalloproteinase 2) inhibitors

By Zheng Jianbin   Wen Ren   Guillaume Dominique  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 23, Iss. 4, 2008-08 ,pp. : 445-453

Informa Healthcare

Access to resources Recommend Favorite

1,2-Diaryl-1-ethanone and pyrazolo [4,3-c] quinoline-4-one as novel selective cyclooxygenase-2 inhibitors

By Baruah B.   Dasu K.   Vaitilingam B.   Vanguri A.   Rao Casturi S.   Rao Yeleswarapu K.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 445-448

Elsevier

Access to resources Recommend Favorite